Angela G Hausberger

Title: Angela G Hausberger: Innovator in Pharmaceutical Formulations

Introduction

Angela G Hausberger is a notable inventor based in East Lyme, Connecticut. She has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications used to treat psychoses such as schizophrenia. Her work has been recognized for its potential impact on patient care and treatment efficacy.

Latest Patents

Angela holds a patent for "Ziprasidone formulations." This patent describes compositions comprising crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles that have a mean particle size of less than 85 micrometers. These formulations, combined with a pharmaceutically acceptable carrier, are substantially bioequivalent and can be utilized in the treatment of psychoses.

Career Highlights

Angela is currently employed at Pfizer Corporation, a leading global pharmaceutical company. Her role involves research and development, focusing on innovative solutions to improve mental health treatments. With her expertise, she has contributed to advancing pharmaceutical science and enhancing therapeutic options for patients.

Collaborations

Angela has collaborated with esteemed colleagues, including Daniel R Arenson and Frank R Busch. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.

Conclusion

Angela G Hausberger's work exemplifies the vital role of inventors in advancing medical science. Her contributions to ziprasidone formulations highlight the importance of innovation in improving treatment options for mental health disorders.